Secondary autoimmune hypothalamitis with severe memory impairment 7 years after the onset of diabetes insipidus due to lymphocytic hypophysitis: a case report
Takahiro Asada,
Shintaro Takenoshita,
Mayuko Senda,
Koichiro Yamamoto,
Ryo Sasaki,
Fumio Otsuka,
Seishi Terada,
Norihito Yamada
Affiliations
Takahiro Asada
Department of Neuropsychiatry, Okayama University Hospital
Shintaro Takenoshita
Department of Neuropsychiatry, Okayama University Hospital
Mayuko Senda
Department of Neuropsychiatry, Okayama University Hospital
Koichiro Yamamoto
Department of General Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Ryo Sasaki
Department of Neurology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Fumio Otsuka
Department of General Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Seishi Terada
Department of Neuropsychiatry, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Norihito Yamada
Department of Neuropsychiatry, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Abstract Background Autoimmune hypothalamitis is a very rare neuroendocrine disorder that causes central diabetes insipidus, headache, visual impairment, and sometimes cognitive impairment. Autoimmune hypothalamitis may occur in association with autoimmune hypophysitis, including lymphocytic hypophysitis, or in isolation. It is not known whether autoimmune hypothalamitis and autoimmune hypophysitis are consecutive diseases. Case presentation A 52-year-old woman developed autoimmune hypothalamitis 7 years after developing central diabetes insipidus due to lymphocytic hypophysitis, resulting in severe memory impairment. High-dose intravenous methylprednisolone therapy improved her cognitive function and decreased the size of the lesion. Conclusion This case presented a unique clinical course, with a long period of time between the onset of autoimmune hypopituitaritis and the development of autoimmune hypothalamitis.